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Abstract
While global success in cessation advocacy has seen smoking rates fall in many developed countries, persistent lung
inflammation in ex-smokers is an increasingly important clinical problem whose mechanistic basis remains poorly
understood. In this study, candidate effector mechanisms were assessed in mice exposed to cigarette smoke (CS) for 4
months following cessation from long term CS exposure. BALF neutrophils, CD4+ and CD8+ T cells and lung innate NK cells
remained significantly elevated following smoking cessation. Analysis of neutrophil mobilization markers showed a
transition from acute mediators (MIP-2a, KC and G-CSF) to sustained drivers of neutrophil and macrophage recruitment and
activation (IL-17A and Serum Amyoid A (SAA)). Follicle-like lymphoid aggregates formed with CS exposure and persisted
with cessation, where they were in close anatomical proximity to pigmented macrophages, whose number actually
increased 3-fold following CS cessation. This was associated with the elastolytic protease, MMP-12 (macrophage metallo-
elastase) which remained significantly elevated post-cessation. Both GM-CSF and CSF-1 were significantly increased in the
CS cessation group relative to the control group. In conclusion, we show that smoking cessation mediates a transition to
accumulation of pigmented macrophages, which may contribute to the expanded macrophage population observed in
COPD. These macrophages together with IL-17A, SAA and innate NK cells are identified here as candidate persistence
determinants and, we suggest, may represent specific targets for therapies directed towards the amelioration of chronic
airway inflammation.
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Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a debilitat-
ing lung condition that is characterized by chronic airway
inflammation. COPD is now the third cause of death worldwide
and kills more than 3.5 million people per year. About 85% of all
COPD is caused by inhalation of irritants mostly cigarette smoke
(active and passive), ambient air pollutants and poor indoor air
quality caused by biomass cooking and heating fumes. Inflamma-
tion induced by these irritants contributes to key pathological
processes in COPD including small airway narrowing, destruction
of alveolar walls (emphysema) and mucous hypersecretion
(reviewed in [1]). Innate immune cells including macrophages
and neutrophils accumulate and are considered essential for
disease progression [2], as are immune cells of the adaptive
response including CD8+ T cells [3]. CD4+ T cells and B cells also
aggregate and can organize into lymphoid follicles, the percentage
of which increases with progression of COPD [2]. The close
association of de novo lymphoid follicles with persistence and
severity of COPD strongly suggests their contribution to delete-
rious autoimmunity in the airways although beneficial effects in
terms of mounting a rapid immune response to respiratory
pathogens have not been formally excluded. The combined
activity of the these inflammatory cells is thought to drive the
accelerated decline in lung function that is a hallmark of the
disease.
Cigarette smoke (CS) cessation currently remains the single
most effective strategy to reduce the accelerated decline in lung
function attributable to COPD. At least in developed countries
there is clear evidence that smoking rates have fallen, in part due
to effective cessation strategies. However, cross-sectional and
longitudinal studies have shown that in individuals with established
disease, airway inflammation does not fully resolve with CS
cessation [4,5] and post cessation persistent lung disease is an
increasingly important clinical problem. In particular, airway and
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sputum neutrophils persist and in some cases, increase with
cessation [4–6]. Neutrophilic inflammation is particularly damag-
ing in COPD due to a deficiency in efferocytosis (clearance of
moribund cells) mediated by excessive oxidative stress [7,8], which
can lead to excessive degranulation of necrotic neutrophils.
Activated neutrophils release neutrophil elastase and other serine
proteases, which increases with the severity of COPD and these
processes are intrinsically insensitive to inhaled glucocorticoster-
oids [9]. Neutrophil elastase degrades extracellular matrix
components including elastin, collagens I–IV and fibrinogen and
the degree of elastase localized to lung elastic fibers correlates with
the degree of emphysema [10]. Neutrophil elastase can also
promote mucin production [11] and activate TLR4-dependent
production of IL-8 via epidermal growth factor receptor (EGFR)
transactivation mechanisms [12].
Macrophages also accumulate in COPD airways and are
positively associated with disease severity [2]. Importantly,
depletion of macrophages protected against the development of
emphysema in a chronic smoke exposure model; demonstrating a
pathogenic role for this immune cell [13]. Furthermore, it is now
recognized that macrophages acquire a distinct phenotype
associated with the progressive induction of M2-related programs
as a consequence of smoke exposure and COPD [14]. Macro-
phages can initiate neutrophilic inflammation as they are a major
source of neutrophil chemokines. Several neutrophil chemokines
such as IL-8 (CXCL8), KC (CXCL1) and MIP-2a (CXCL2) are
implicated in COPD as they are elevated in CS exposure models
[15] and during exacerbations [16]. In addition, Interleukin-17A
(IL-17A) can promote neutrophil mobilization through its
regulation of leukocyte growth factors and cytokines. Immunore-
active IL-17A+ cells increase in frequency in the submucosa of
COPD patients [17] and IL-17A expression is elevated in CS
exposure models, where mice lacking IL-17RA were protected
from developing emphysema [18]. Serum Amyloid A (SAA) can
also mobilize neutrophils into the airways, and SAA is elevated in
COPD lung tissue [19] and is related to neutrophilic lung
infiltration [20]. In this study, a CS cessation model was used to
identify which molecular markers most closely relate to the
persistence of innate immune responses. We identify IL-17A and
SAA inflammatory cytokine networks in the persistence of
inflammation following CS cessation and suggest that targeting
these networks may be of therapeutic benefit in augmenting the
benefit of smoking cessation in this disease group.
Materials and Methods
Animals
Specific pathogen-free male BALB/c mice obtained from the
Animal Resource Centre (Perth, Australia) arrived at 6 weeks of
age were housed at in sterile micro-isolator cages, and maintained
on a 12:12 h light/dark cycle. This study was carried out in strict
accordance with the National Health and Medical Research
Council (NHMRC) of Australia. All procedures were approved by
the Animal Experimentation Ethics Committee of the University
of Melbourne.
Treatment
After a one week acclimatization period, mice were randomly
divided into 4 groups (n = 14–18 per group) that were matched for
body weight. Two groups of animals were exposed to cigarette
smoke (CS) and two groups were sham exposed according to our
published protocol [21,22]. Briefly, animals underwent whole
body exposure to the smoke of 1 filtered cigarette inside an 18 liter
plastic chamber (Winfield Red, 16 mg or less of tar, 1.2 mg or less
of nicotine and 15 mg or less of CO, Philip Morris) over 15 min
with a 5 minute recovery interval and this was then repeated such
that mice received 2 cigarettes over a 30 min period. Smoke was
generated in 50-ml tidal volumes over 10 seconds by use of timed
draw-back. The mean total suspended particulate (TSP) mass
concentration in the chamber containing cigarette smoke gener-
ated from one cigarette, measured from 3 min 13 s to 15 min, was
419 mg/m3 as previously published [22]. This exposure protocol
was repeated three times a day (8 am, 12 pm and 4 pm exposures)
for 6 days a week and generates carboxyhemoglobin levels within
the range observed in human smokers [22]. Sham animals were
handled identically without cigarette smoke exposure. After 16
weeks of CS one group of mice was sacrificed, as described below.
The remaining groups were then sacrificed after a period without
CS of 4 and 12 weeks. Body weight was measured twice per week.
Tissue Collection
The study protocol included 4 groups (n = 11–14 per group).
Mice were weighed and given an anesthetic overdose (ketamine
and xylazine, 180 and 32 mg/kg i.p., respectively) and allocated to
the following experimental protocols. Cohort 1 (n = 8) were
subjected to bronchoalveolar lavage (BAL). Briefly, lungs from
each mouse were lavaged in situ with 0.4 ml PBS, followed by
three 0.3 mL of PBS, with 1 ml of BAL fluid (BALF) recovered
from each animal. Smoke exposure had no effect on the recovered
volume as previously shown [22]. Whole lungs were perfused free
of blood via right ventricular perfusion with 10 ml of saline,
rapidly excised en bloc, blotted. The large left lobe was snap
frozen in liquid nitrogen and stored at 280uC for QPCR analysis.
The remaining lung tissue was retained and subjected to flow
cytometry analysis as detailed in the flow cytometry methods
section. Cohort 2 (n = 5–6) were subjected to histology as detailed
in the histology methods section.
Cellular Inflammatory Response
Bronchoalveolar lavage fluid (BALF) was collected as previously
described [22]. Cytospins were prepared at 400 rpm for 10 min
on a Cytospin 3 (Shandon, UK). Cytospin slides were stained with
DiffQuik (Dade Baxter, Australia) and 500 cells per slide were by
standard morphological criteria.
Flow Cytometry
BALF cells were resuspended in FACS buffer (PBS 1% FCS).
Lungs were perfused with ice-cold PBS to remove excess blood
before single cell suspensions were obtained using collagenase.
Briefly, whole lungs were digested with RPMI containing
collagenase D (1 mg/mL) and DNase I (Roche, Mannheim,
Germany) and cells were washed and recovered by centrifugation.
Erythrocytes were lysed by incubation with RBC lysis buffer. To
avoid non-specific binding of Abs to FcRc, FACS Buffer
containing anti-mouse CD16/32 mAb (Mouse BD Fc Block)
(2.4G2, BD) was added to all primary stains. Cells were labeled
with fluorophore-conjugated antibodies at pre-optimized dilutions
to CD3-FITC, CD4-PE, CD8-PE, CD49b-PE (NK/NK T
marker) and CD69-FITC (all from Becton Dickinson) for 1 h at
4uC and then washed twice in FACS buffer and resuspended in a
final volume of 0.5 ml of FACS buffer. Data was acquired on a BD
FACSCalibur flow cytometer (Becton Dickinson) and typically up
to 105 viable cell events were collected for analysis. A strict gating
strategy was used to determine different immune cell populations
as follows: single cell gate (FSC-H vs FSC-A), live cells (propidium
iodide exclusion), granularity/size cell gate (FSC-A vs SSC-A) and
specific surface marker gates. Flowjo software (version 7.2.4, Tree
Star, OR) was used to generate plots for data analysis.
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Histology
Mouse lungs (n = 5–6 per group) were perfusion fixed in situ via
a tracheal cannula with 10% neutral buffered formalin (NBF) at
25 cm H2O pressure. After 10 min, the trachea was ligated and
the lungs were left in situ for 1 hr, then removed and immersed in
10% NBF for at least 24 hr and then embedded in paraffin. After
paraffin embedding, 4 mm sections were prepared and stained
with hematoxylin and eosin. The number of pigmented macro-
phages was counted by a treatment-blind observer at x200
magnification, with at least 8 fields captured per sample for
analysis using ImageJ software. Assessment of the number of
lymphoid follicles per mm2 of lung tissue was determined as
previously published [23].
Quantitative RT-PCR
Total RNA was isolated from lung tissue using an RNeasy kit
(Qiagen, MD, USA) and was used as a template to generate first-
strand cDNA synthesis using SuperScript III (Invitrogen, CA,
USA). TaqMan low density arrays (Applied Biosystem, CA, USA)
were used for determining gene expression of individual samples
using an ABI 7900 HT Sequence Detection System (Applied
Biosystems). Gene expression was quantified using 18S rRNA as
an internal control as previously described [22].
Statistical Analyses
Results are expressed as mean 6 SE. All data were analyzed
using two-way ANOVA and when statistical significance was
achieved a post hoc Bonferroni test for multiple comparisons was
used to compare between treatment groups. All statistical analyses
were performed with GraphPad Prism for Windows (version 6.02).
In all cases, probability values less than 0.05 (P,0.05) were
considered statistically significant.
Results
Cessation of CS exposure restored body weight
As previously reported [24,25] mice exposed to CS failed to
gain as much body weight as the Sham handled mice and were
15% lighter at the conclusion of the 16 week exposure period (P,
0.05; Figure 1). After smoking cessation mice rapidly gained
weight but remained significantly lighter by 6% after 4 weeks of
recovery (P,0.05). By 12 weeks of recovery the body weight of
mice previously exposed to CS was no different to the sham
handled mice. Since the systemic effects of cigarette smoke resolve
by 12 weeks, the cellular and molecular markers were character-
ized at this time point. In addition, following 16 weeks of smoke
exposure, no significant increase in airspace enlargement was
observed in BALB/c mice, which is consistent with previous
studies that show an increase in mean linear intercept and
destructive index in longer term chronic exposure models (i.e. 6
months) [26].
Neutrophil and lymphocyte cell number remained
elevated after 12 weeks of CS cessation
Mice exposed to CS for 16 weeks (6 cigarettes/day, 6 days/
week) had a significant increase in total, macrophage and
neutrophil number in BALF compared to sham mice (P,0.05,
Figure 2A–C). Following 12 weeks of CS cessation BALF
macrophage and total cell number decreased to sham levels. Peak
neutrophil numbers in CS exposed mice declined by approxi-
mately 10-fold in the 12 weeks CS cessation group, however
remained significantly elevated by 5-fold compared to Sham mice
(P,0.05, Figure 2C). FACS analysis was used to determine the
number of Ly6G+ neutrophils in the lung tissue, which showed
that tissue neutrophils accumulated with CS exposure, resulting in
a 1.6-fold increase above sham exposed mice (Figure 2D). Unlike
neutrophil numbers in the BALF, tissue associated neutrophil
numbers in the CS cessation group normalized to sham levels
(Figure 2D).
Figure 1. Smoke-induced weight loss was reversed 12 weeks after CS cessation.Male BALB/c mice were either exposed to 6 cigarettes/day,
6 days/week (&) or sham handled (m) for 16 weeks. After smoke exposure, groups of mice were then exposed to room air without cigarette smoke
for either 4 weeks (=) or 12 weeks (¤). For all groups body weight was determined weekly. Data are shown as mean 6 SE for n = 14–18 per
treatment group.
doi:10.1371/journal.pone.0113180.g001
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FACS analysis was used to determine CD3+ CD4+ and
activated CD69+CD8+ T cell number in BALF and lung tissue
(Figure 3A–F). In lung tissue, CS had no effect on CD4+ T cell
numbers and no change in frequency was observed in the
cessation groups (Figure 3A). CD4+ T cells were also analyzed in
the BALF compartment following 12 weeks CS recovery,
demonstrating a 1.6-fold increase above Sham exposed mice
(Figure 3B). Activated CD8+ T cells were also quantified by flow
cytometry in the lung tissue, demonstrating a significant 2.3-fold
increase in CS-exposed mice above Sham controls (Figure 3C).
There was also a trend towards increased CD8+ T cell numbers in
the CS cessation group (1.5-fold); however this failed to reach
statistical significance. Analysis of BALF CD8+ T cells numbers
demonstrated a 2.4-fold increase in the recovery group compared
to the Sham controls (Figure 3D). In addition, activated NK cells
were quantified in the lung and BAL compartment demonstrating
a 2-fold increase in the lung tissue that was maintained in the CS
cessation group (Figure 3E). In contrast there was no increase in
activated NK cells in the BAL compartment (Figure 3F).
Cigarette smoke exposure induced lymphoid aggregates
and the prolonged elevation in pigmented macrophages
Hematoxylin and eosin staining of lung sections revealed the
presence of structures consistent with the formation of lymphoid
aggregates, a hallmark of chronic inflammation in CS exposed
mice, which persisted following 12 weeks of cessation (Figure 4A).
Quantification of the number of tertiary lymphoid aggregates
demonstrated that these structures appeared with 16 weeks of CS
exposure and consistent with a recent study [23], persisted in the
cessation group where numbers appeared to slightly increase over
time (Figure 4B). The lymphoid aggregates were anatomically
located in close proximity to pigmented macrophages. The
Figure 2. Effect of sub-chronic smoke exposure and 12 weeks of CS cessation on BALF cellularity and lung neutrophilia. Male BALB/c
mice were either exposed to 6 cigarettes/day, 6 days/week (&) or sham handled (%) for 16 weeks. After smoke exposure a group of mice was then
exposed to room air without cigarette smoke for 12 weeks. Total cells (A), macrophages (B) and neutrophils (C) were determined in BALF. Data are
shown as mean6 SE for n = 8–11 per treatment group. (D) Single cell suspension of the lungs was used to determine neutrophil numbers in the lung
tissue by flow cytometry. Data were analysed by two-way ANOVA and when significance was achieved a post hoc Bonferroni test was performed.
#P,0.05 significant post hoc effect of CS compared to sham animals at the same recovery time-point.
doi:10.1371/journal.pone.0113180.g002
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Figure 3. Effect of sub-chronic smoke exposure and 12 weeks of CS cessation on BALF and lung CD4+ and activated CD8+
lymphocytes. Male BALB/c mice were either exposed to 6 cigarettes/day, 6 days/week (&) or sham handled (%) for 16 weeks. After smoke
exposure a group of mice was then exposed to room air without cigarette smoke for 12 weeks. CD4+CD3+ lymphocyte number was determined in
individual lung single cell suspensions (A) and BALF cells (B) using FACS analysis. Activated CD8+CD69+ lymphocyte number was determined in
individual lung single cell suspensions (C) and BALF cells (D) using FACS analysis. In addition, activated NK cell numbers were quantified in individual
lung single cell suspensions (E) and BALF cells (F). Data are shown as mean 6 SE for n = 7–8 per treatment group. Data were analysed by two-way
ANOVA and when significance was achieved a post hoc Bonferroni test was performed. #P,0.05 significant post hoc effect of CS compared to sham
animals at the same recovery time-point.
doi:10.1371/journal.pone.0113180.g003
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Figure 4. Sub-chronic smoke exposure resulted in the prolonged presence of pigmented macrophages. Representative histological
staining of hematoxylin and eosin sections from sham and CS exposed mice and after 12 weeks of recovery (A). Magnification, x100 and x1000. The
histological sections were scored for the number of lymphoid aggregates (B). The histological sections were scored for the presence of pigmented
macrophages (C). Gene expression of the macrophage survival cytokines GM-CSF (D) and CSF-1 (E) was determined by Q-PCR, normalized to 18S
rRNA and expressed as a fold change relative to the Sham no recovery group. Data are shown as mean 6 SE for n = 7–8 per treatment group for
QPCR and n= 4–6 for immunhistochemistry. Data were analysed by two-way ANOVA and when significance was achieved a post hoc Bonferroni test
was performed. #P,0.05 significant post hoc effect.
doi:10.1371/journal.pone.0113180.g004
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accumulation of brown pigmented macrophages in the CS mice
was quantified by a blind observer. CS exposure induced a
significant increase in pigmented macrophages compared to sham
mice (P,0.05, Figure 4C). Cessation resulted in a further 3-fold
increase in the numbers of pigmented macrophages when
compared to mice analyzed immediately after the 16 weeks of
CS exposure (P,0.05, Figure 4C). Gene expression analysis of
macrophage colony stimulating factors known to promote the
survival and proliferation of leukocytes demonstrated that CS
exposure caused a significant induction of GM-CSF mRNA
compared to sham animals and this increase persisted following 12
weeks of cessation (P,0.05, Figure 4D). The mRNA expression of
CSF-1 was also significantly induced after 12 weeks of CS
cessation (P,0.05, Figure 4E).
Differential effects of CS cessation on markers of
alternative macrophage activation and neutrophil
mobilization
Expression of markers of alternative macrophage activation,
MMP-12 and IL-10, was examined by QPCR of the lung tissue.
CS caused a marked induction of MMP-12 gene expression (36-
fold) and this remained significantly elevated by 19-fold after 12
weeks of cessation compared to sham animals (P,0.05, Fig-
ure 5A). IL-10 mRNA expression was also significantly elevated in
the CS group after 12 weeks of smoking cessation compared to
sham mice (P,0.05, Figure 5B).
The mRNA expression of neutrophil mobilization mediators
was also examined. CS exposure significantly increased the
mRNA expression of MIP-2a, KC and G-CSF compared to
sham mice (P,0.05, Figure 6). 12 weeks of CS cessation resulted
in a significant reduction in the mRNA expression of MIP-2a (2.3-
fold), KC (2.3-fold) and G-CSF (2.1-fold) when compared to mice
that were analyzed immediately following CS (P,0.05). Expres-
sion of the alternative neutrophil mobilizing mediators, IL17A and
SAA, significantly increased by 9-fold and 33-fold above sham
exposed mice respectively (P,0.05, Figure 7). IL-17A transcript
levels did not decrease with CS cessation, where there was a 13-
fold increase in the CS cessation group (Figure 7A). Although
there was a trend towards reduced expression of SAA transcript in
the CS cessation group (17-fold above sham), this was not
significantly different to levels in CS exposed mice (Figure 7B). In
addition, the well characterized TH17 polarising cytokines IL-6
(Figure 7C) and IL23 (Figure 7D) were measured by QPCR in the
lung tissue. IL-6 levels were increased by 16 weeks of CS exposure;
however there was no difference in IL-6 expression in the CS
cessation arm. IL23 levels did not significantly increase with 16
weeks CS exposure.
Discussion
COPD is a disease that displays a complex immunological
profile associated with the engagement of innate and adaptive
cellular processes in response to chronic CS exposure. Immune
cells of both the innate and adaptive response persisted in our CS
cessation model and this was previously associated with a modest
reduction of alveolar enlargement and increased pulmonary
compliance [27]. The innate response is particularly active in
COPD, where macrophages and neutrophils accumulate in
COPD airways [28], and neutrophilic inflammation fails to fully
Figure 5. Effect of sub-chronic smoke exposure and 12 weeks
of CS cessation on alternative macrophage marker mRNA
expression in lung tissue. Male BALB/c mice were either exposed to
6 cigarettes/day, 6 days/week (&) or sham handled (%) for 16 weeks.
After smoke exposure a group of mice was then exposed to room air
without cigarette smoke for 12 weeks. Gene expression of the
alternative macrophage markers, MMP-12 (A) and IL-10 (B) was
determined by Q-PCR, normalized to 18S rRNA and expressed as a
fold change relative to the Sham 0 weeks recovery group. Data are
shown as mean 6 SE for n = 7–8 per treatment group. Data were
analysed by two-way ANOVA and when significance was achieved a
post hoc Bonferroni test was performed. #P,0.05 significant post hoc
effect.
doi:10.1371/journal.pone.0113180.g005
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resolve in response to CS cessation [4,5]. Our experimental model
displayed a similar response to CS cessation where neutrophilic
inflammation in the BAL compartment reduced with cessation but
failed to fully resolve to control levels. In contrast, tissue
neutrophils declined to control levels with CS cessation, which
was consistent with the decline in G-CSF, a major hematopoietic
growth factor required for mobilization and maturation of
granulocyte precursors. Given the short-lived nature of blood
derived neutrophils, the low level persistence of neutrophils in the
BAL compartment is characteristic of an inflammatory response
that has failed to fully resolve.
In addition, the adaptive response was also engaged, where
increased CD4+ and CD8+ lymphocyte numbers in the BALF
compartment remained elevated following CS cessation. Although
total lymphocyte numbers in lung tissue were not significantly
increased in the CS cessation group, there was an accumulation of
lymphoid follicle-like structures in response to CS exposure that
persisted in the cessation group. This is consistent with a recent
report, where the persistence of lymphoid aggregates was
associated with increased anti-nuclear autoantibody (ANA) pro-
duction [23]. The role of these organized structures remain to be
fully resolved, however therapeutic targeting of lymphoid follicle
formation in mice chronically exposed to CS failed to suppress
airway remodeling and alveolar enlargement [29]. There was also
an increase in innate lymphoid NK cells in CS exposed mice,
which persisted in the cessation group. This is consistent with the
observed increase in NK cells in the induced sputum of COPD
patients [30]. In a chronic CS challenge model, NK cells were
shown to be more primed to release inflammatory mediators
including IL-12 and IL-18 [31]. It has also been shown that the
NK cell group 2D (NKG2D) ligand is increased in response to CS-
exposure [32], which can sustain activation of cytotoxic T cells
including NK cells.
CS models consistently show increased macrophage numbers in
the BALF compartment (reviewed in [33]) and elevated macro-
phage numbers have been observed in other CS cessation models
[27]. Here, we observed the persistence of pigmented macrophage
populations that typically clustered together in regions adjacent to
lymphoid aggregates. The presence of pigmented macrophages is
thought to be related to the accumulation of CS products ingested
by resident lung macrophages. To the best of our knowledge, this
is the first study to quantify pigmented macrophages and
demonstrate an increase with CS cessation. In conjunction with
increased pigmented macrophage numbers, leukocyte colony
stimulating factors, GM-CSF and CSF-1 transcript were signifi-
cantly increased in the CS cessation group. Both CSFs are known
to promote survival, proliferation and differentiation of myeloid
lineages, and the findings presented here suggest that pigmented
macrophages may proliferate in response to increased CSF
expression. Whether these pigmented macrophages represent a
distinct phenotype in COPD that contribute to disease pathobi-
ology remains to be determined. There is however, growing
evidence that macrophages do not conform to the classic M1/M2
Figure 6. Effect of sub-chronic smoke exposure and 12 weeks
of CS cessation on classic neutrophil mobilization mediators.
Male BALB/c mice were either exposed to 6 cigarettes/day, 6 days/week
(&) or sham handled (%) for 16 weeks. After smoke exposure a group
of mice was then exposed to room air without cigarette smoke for 12
weeks. Gene expression of MIP-2a (A), KC (B) and G-CSF (C) was
determined by Q-PCR, normalized to 18S rRNA and expressed as a fold
change relative to the Sham group. Data are shown as mean 6 SE for
n = 7–8 per treatment group. Data were analysed by two-way ANOVA
and when significance was achieved a post hoc Bonferroni test was
performed. #P,0.05 significant post hoc effect.
doi:10.1371/journal.pone.0113180.g006
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dichotomy in COPD [14,34]. In this study, IL-10 and MMP-12
expression were used as markers for differential macrophage
polarization as previously reported [34], and increased expression
suggest that alternative macrophage populations persist and
contribute to chronic inflammation.
Previous global expression studies have shown that the majority
of CS-inducible genes decline with cessation [35]. In our study,
there was a focus on genes involved in neutrophil mobilization that
are known to be upregulated in COPD. We have shown that IL-
17A and SAA were not significantly reduced in the CS cessation
group, in contrast to MIP-2a, KC and G-CSF that significantly
declined with recovery. Our previous studies have demonstrated
intense SAA immunoreactivity [19] and a positive correlation with
neutrophilic airway inflammation [20] in the lungs of COPD
patients. SAA is also a ligand for the GPCR termed ALX/FPR2,
where SAA is a potent chemotactic factor that mediates phagocyte
migration via this receptor [36]. SAA also promotes airway
neutrophilic inflammation in a manner that is opposed by the
eicosanoid, LipoxinA4 [19]. Lipoxins and resolvins are alternative
lipid-based ALX/FPR2 ligands that can oppose the actions of
SAA and actively promote the resolution of inflammation
(reviewed in [37,38]). Hence, the relative abundance of alternative
ALX/FPR2 ligands may contribute to the impairment of
resolution, where increased SAA may skew the balance towards
a pro-inflammatory state.
SAA has also been shown to promote airway neutrophil
recruitment via IL-17A dependent mechanisms [20]. There is also
emerging evidence for an important role for IL-17A in COPD. IL-
17A+ cells have been shown to be increased in the bronchial
submucosa of chronic smokers and stable COPD subjects [17,39].
Furthermore, genetic ablation of the IL-17R in experimental CS
models protected the mice against the development of emphysema
[18], hence identifying IL-17A as a major inflammatory cytokine
that can drive pathological inflammation. Recent studies also
Figure 7. Effect of sub-chronic smoke exposure and 12 weeks of CS cessation on IL-17A and SAA expression. Male BALB/c mice were
either exposed to 6 cigarettes/day, 6 days/week (&) or sham handled (%) for 16 weeks. After smoke exposure a group of mice was then exposed to
room air without cigarette smoke for 12 weeks. Gene expression of IL-17A (A), SAA (B), IL-6 (C) and IL23 (D) was determined by Q-PCR, normalized to
18S rRNA and expressed as a fold change relative to the Sham group. Data are shown as mean 6 SE for n= 6–8 per treatment group. Data were
analyzed by two-way ANOVA and when significance was achieved a post hoc Bonferroni test was performed.
doi:10.1371/journal.pone.0113180.g007
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demonstrate that neutrophilic inflammation induced by CS
exposure is potently suppressed in mice deficient in IL-17A [40]
and in response to neutralisation with a blocking antibody [41].
Furthermore, inhibition of IL-17A signaling in an experimental
COPD model also suppressed accumulation of macrophages in
response to CS exposure [18]. Our finding of persistent IL-17A
expression in the CS cessation group is consistent with a recent
study that identified an increase in the frequency of IL-17A
expressing CD4+ (TH17) and CD8
+ (TC17) T cells in CS exposed
mice [42]. In our study, known TH17 cytokines were also
quantified by QPCR and showed that IL-6, but not IL23 was
significantly increased in response to CS exposure. This finding is
consistent with our previous study that investigated TH17 cytokine
expression in response to SAA stimulation, where IL-6 was
predominately induced [20]. Although SAA levels were not
significantly reduced with CS cessation, there was a trend towards
reduced expression relative to the non-cessation group and IL-6
levels were not increased in the CS cessation group. This data
suggests that SAA and IL-6 can be sufficient to initiate polarization
and maturation of IL-17A expressing cellular populations in CS
exposed lungs, however once established, IL-17A+ cells may be
maintained in the mucosa independently of TH17 cytokines.
In addition to classic TH17 pathways, there is also emerging
evidence for alternative innate cellular sources of IL-17A in
inflammatory lung models. This may be particularly relevant to
COPD as NOD. SCID mice deficient in B and T cells still develop
airspace enlargement in response to chronic CS exposure, to
suggest a more prominent role for innate immune responses [43].
Indeed, innate sources of IL-17A have been identified in
inflammatory lung models including macrophages, neutrophils,
NK cells and cd T cells [20,44] and the predominant source of IL-
17A in COPD is yet to be defined. In conclusion, this study has
investigated innate and adaptive responses following CS cessation
and has identified the IL-17A and SAA innate cytokine networks
as markers of persistent inflammatory responses. The targeting of
the IL-17A axis may represent a novel therapeutic strategy to
promote the resolution of inflammation following CS cessation.
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